16292 Search Results Found For:

Cabot Micro-Cap Insider Special Bulletin

This morning, we received bad news from Medexus. Medexus announced that it has received a complete response letter from the FDA related to Treosulfan, its newly in-licensed drug that was to...

Cabot Profit Booster 186

The overall market continues to trade without much conviction at the moment. Last week, the S&P 500 fell 0.37%, the Dow declined 0.36% and the Nasdaq pulled back As...

Cabot Profit Booster 186

Last week, the S&P 500 fell 0.37%, the Dow declined 0.36% and the Nasdaq pulled back 1.11%. As I’ve pointed out over the past few weeks, the bullish has...

Cabot Stock of the Week 359

The bull market remains intact, so I continue to recommend that you be heavily invested in stocks that help achieve your investing goals. Today’s featured stock provides a cloud-based that...
5 Signs of a Stock Market Top

5 Signs of a Stock Market Top

With stocks at fresh highs, is a stock market top imminent? Here are five ways to know if the bull market is starting to die of old age.

Cabot Turnaround Letter Weekly Update

Today’s note includes earnings updates on 12 companies, the podcast and the Catalyst Report. We publish the Catalyst Report on the Friday after each monthly issue of the Cabot Letter...
10 Rules for Growth Investing

10 Rules for Growth Investing

These growth investing rules have been carefully selected as the most important guidelines a growth investor can use in a successful investment program.

Cabot Prime Pro Week Ending July 30, 2021

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to what...

Cabot Prime Week Ending July 30, 2021

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to what...

Cabot Growth Investor 1477

There remains a lot of choppy action, where it seems like one stock does well and another hits a pothole. But we also continue to see improvement among stocks,...